Evidence map›Paper›PMID 24779422›Full record

ArticleRetrovirology2014

Mouse mammary tumor virus-based vector transduces non-dividing cells, enters the nucleus via a TNPO3-independent pathway and integrates in a less biased fashion than other retroviruses.

Constantine James Konstantoulas, Stanislav Indik

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Interactions between Retroviruses and the Host Cell Genome.Molecular therapy. Methods & clinical development · 2018
    Review
  11. The Retrovirus Capsid Core.Sub-cellular biochemistry · 2018
    Review
  12. Article
  13. Article
  14. Retroviral DNA Integration.Chemical reviews · 2016
    Review
  15. Article
  16. Sites of retroviral DNA integration: From basic research to clinical applications.Critical reviews in biochemistry and molecular biology · 2016
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Constantine James Konstantoulas
Stanislav IndikInstitute of Virology, University of Veterinary Medicine Vienna, Veterinaerplatz 1, Vienna 1210, Austria. Stanislav.Indik@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · AT

Funding

Austrian Science Fund FWF P 21494
6 · The paper itself

Abstract

backgroundMouse mammary tumor virus (MMTV) is a complex, milk-born betaretrovirus, which preferentially infects dendritic cells (DC) in the gastrointestinal tract and then spreads to T and B lymphocytes and finally to the mammary gland. It is not clear how the prototypic betaretrovirus infects mucosal DCs and naïve lymphocytes as these cells are considered to be non-proliferative. Studies of MMTV biology have been hampered by the difficulty of obtaining sufficient virus/vector titers after transfection of a molecular clone in cultured cells. To surmount this barrier we developed a novel MMTV-based vector system with a split genome design containing potent posttranscriptional regulatory functions.

resultsUsing this system, vector particles were produced to markedly greater titers (>1000-fold) than those obtained previously. The titers (>106 transduction units /ml) were comparable to those achieved with lentiviral or gammaretroviral vectors. Importantly, the vector transduced the enhanced green fluorescence protein gene into the chromosomes of non-dividing cells, such as cells arrested at the G2/M phase of the cell cycle and unstimulated hematopoietic progenitor cells, at an efficiency similar to that obtained with the HIV-1-based vector. In contrast to HIV-1, MMTV transductions were not affected by knocking down the expression of a factor involved in nuclear import of the HIV-1 pre-integration complexes, TNPO3. In contrast to HIV-1, the MMTV-based vector did not preferentially integrate in transcription units. Additionally, no preference for integration near transcription start sites, the regions preferentially targeted by gammaretroviral vectors, was observed. The vector derived from MMTV exhibits a random integration pattern.

conclusionsOverall, the betaretroviral vector system should facilitate molecular virology studies of the prototypic betaretrovirus as well as studies attempting to elucidate fundamental cellular processes such as nuclear import pathways. Random integration in cycling and non-cycling cells may be applicable in unbiased gene delivery.

Indexed as

Animalsbeta KaryopherinsCell LineCell Line, TumorCell NucleusG2 Phase Cell Cycle CheckpointsGene ExpressionGenetic VectorsGreen Fluorescent ProteinsHEK293 CellsHeLa CellsHIV-1HumansMammary Tumor Virus, MouseMiceRetroviridaebeta Karyopherinsenhanced green fluorescent proteinGreen Fluorescent Proteins

Identifiers

PMID24779422
PMCPMC4098793
OpenAlexW2160718131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.